Microcrystalline Chitosan is Ineffective to Decrease Plasma Lipids in both Apolipoprotein E epsilon4 Carriers and Non-Carriers: A Long-Term Placebo-Controlled Trial in Hypercholesterolaemic Volunteers-Reference-Cited by-同舟云学术

Microcrystalline Chitosan is Ineffective to Decrease Plasma Lipids in both Apolipoprotein E epsilon4 Carriers and Non-Carriers: A Long-Term Placebo-Controlled Trial in Hypercholesterolaemic Volunteers

Published:2005-08 Issue:2 Volume:97 Page:98-103
ISSN:1742-7835
Container-title:Basic Clinical Pharmacology Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Lehtimaki Terho,Metso Saara,Ylitalo Ritva,Rontu Riikka,Nikkil Matti,Wuolijoki Erkki,Ylitalo Pauli

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Reference23 articles.

1. Bile acid metabolism in familial dysbetalipoproteinaemia: studies in subjects with the apolipoprotein E-2/2 phenotype

2. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype

3. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

4. A Glucomannan and Chitosan Fiber Supplement Decreases Plasma Cholesterol and Increases Cholesterol Excretion in Overweight Normocholesterolemic Humans

5. Cholesterol Absorption and Metabolism and LDL Kinetics in Healthy Men With Different Apoprotein E Phenotypes and Apoprotein B Xba I and LDL Receptor Pvu II Genotypes

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation and antibacterial properties of lollipops containing of chitosan- zinc oxide nano particles on planktonic and biofilm forms of Streptococcus mutans and Lactobacillus acidophilus;BMC Oral Health;2023-12-01

2. Antidiabetic Properties of Chitosan and Its Derivatives;Marine Drugs;2022-12-17

3. The effects of chitosan supplementation on anthropometric indicators of obesity, lipid and glycemic profiles, and appetite-regulated hormones in adolescents with overweight or obesity: a randomized, double-blind clinical trial;BMC Pediatrics;2022-09-05

4. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19;Diagnostic Microbiology and Infectious Disease;2021-01

5. Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis;Nutrition Journal;2020-12